28
Oct
2025

Lavipharm SA

Exhibitor at CPHI Frankfurt 2025 stand 3.1J26, Finished Dosage Formulations
About Us

Lavipharm is an integrated group engaged in the research, development, manufacturing, import, marketing and sales, distribution, and wholesaling of pharmaceutical and healthcare products in Greece, with a strong international activity. Since 1911, the Company has established a solid commercial position in Greece, while over the years it has evolved into a leading developer and manufacturer of drug delivery systems, mainly TTS, both locally and internationally.

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • GR
  • 2019
    On CPHI since
  • 250 - 499
    Employees
Company types
Distributor/Import Export
Manufacturer/Innovator
Wholesale/Retail
View company profile
Contact info
Show contact info Hide contact info
Event information
CPHI Frankfurt 2025
  • 28 Oct 2025 - 30 Oct 2025
  • Messe, Frankfurt
  • Visit us at stand 3.1J26, Finished Dosage Formulations

Products Featured at CPHI Frankfurt 2025

  • Nitrong, Trinipatch, Nitrosylon

    Product Nitrong, Trinipatch, Nitrosylon

    A latest generation nitroglycerin patch for the treatment of coronary artery disease and heart failure. Transdermal Drug Delivery Systems (TDDS) are one of the pharmaceutical technologies, in which Lavipharm is actively and successfully engaged. TDDSs are placed on the skin and allow specific drug subs...
  • Fentadur, Dolfen, Durfenta, Opiodur

    Product Fentadur, Dolfen, Durfenta, Opiodur

    A fentanyl transdermal delivery system, developed by Lavipharm's research laboratories in the USA and approved by the FDA, is a small, thin and easy to adhere patch for the management of chronic pain. It is designed to deliver the analgesic substance fentanyl safely and effectively through the skin. ...